One-Year Real-World Experience with Mavacamten and its Physiologic Effects on Obstructive Hypertrophic Cardiomyopathy

Daniel Kim; Emily Chu; Emily Keamy-Minor; Ishan Paranjpe; Wilson Tang; Jack O'Sullivan; Yaanik Desai; Michael Liu; Elise Munsey; Kimberly Hecker; Isabella Cuenco; Beth Kao; Ellen Bacolor; Colleen Bonnett; Andrea Linder; Kathleen Lacar; Nancy Robles; Cynthia Lamendola; Allysonne Smith; Joshua Knowles; Marco Perez; Masataka Kawana; Karim Sallam; Chad Weldy; Matthew Wheeler; Victoria Parikh; Heidi Salisbury; Euan Ashley

doi:10.20944/preprints202311.1692.v1

Preprint

Case Report

One-Year Real-World Experience with Mavacamten and its Physiologic Effects on Obstructive Hypertrophic Cardiomyopathy

This version is not peer-reviewed.

Altmetrics

Downloads

413

Views

675

Comments

Submitted:

23 November 2023

Posted:

27 November 2023

You are already at the latest version

A peer-reviewed article of this preprint also exists.

Abstract

Keywords:

Subject:

Medicine and Pharmacology - Cardiac and Cardiovascular Systems

Supplementary Material

supplementary.mov (38.39MB )

Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.

Alerts

MDPI Initiatives

Important Links

Choose an area of interest and we will send you notifications of new preprints at your preferred frequency.

Disclaimer

One-Year Real-World Experience with Mavacamten and its Physiologic Effects on Obstructive Hypertrophic Cardiomyopathy

Abstract

Keywords:

Subject:

MDPI Initiatives

Important Links

Subscribe